Impaired Carbon Monoxide Diffusing Capacity is the Strongest Predictor of Exercise Intolerance in COPD

References

• Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370(9589):765–773.
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158(5 Pt 1):1557–1565.
   PubMed Web of Science ®Google Scholar
• Serres I, Gautier V, Varray A, Prefaut C. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 1998; 113(4):900–905.
   PubMed Web of Science ®Google Scholar
• Celli BR. Standards for the optimal management of COPD: a summary. Chest 1998; 113(4 Suppl):283S–287S.
   PubMed Web of Science ®Google Scholar
• Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1(6077):1645–1648.
   PubMed Web of Science ®Google Scholar
• Cooper CB. Airflow obstruction and exercise. Respir Med 2009; 103(3):325–334.
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164(5):770–777.
   PubMed Web of Science ®Google Scholar
• Albuquerque AL, Nery LE, Villaca DS, Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III. Eur Respir J 2006; 28(5):939–944.
   PubMed Web of Science ®Google Scholar
• Morrison NJ, Abboud RT, Ramadan F, Comparison of single breath carbon monoxide diffusing capacity and pressure-volume curves in detecting emphysema. Am Rev Respir Dis 1989; 139(5):1179–1187.
   PubMed Web of Science ®Google Scholar
• Balcells E, Anto JM, Gea J, Characteristics of patients admitted for the first time for COPD exacerbation. Respir Med 2009; 103(9):1293–1302.
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Serra I, Gomez FP, Physical activity and clinical and functional status in COPD. Chest 2009; 136(1):62–70.
   PubMed Web of Science ®Google Scholar
• Hadeli KO, Siegel EM, Sherrill DL, Beck KC, Enright PL. Predictors of oxygen desaturation during submaximal exercise in 8,000 patients. Chest 2001; 120(1):88–92.
   PubMed Web of Science ®Google Scholar
• Teixeira PJ, Costa CC, Berton DC, Versa G, Bertoletti O, Canterle DB. [Six-minute walk work is not correlated to the degree of airflow obstruction in patients with Chronic Obstructive Pulmonary Disease (COPD)]. Rev Port Pneumol 2006; 12(3):241–254.
   PubMedGoogle Scholar
• van Wetering CR, van Nooten FE, Mol SJ, Hoogendoorn M, Rutten-Van Molken MP, Schols AM. Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial. Int J Chron Obstruct Pulmon Dis 2008; 3(3):443–451.
   PubMedGoogle Scholar
• Fujimoto H, Asai K, Watanabe T, Kanazawa H, Hirata K. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD). Osaka City Med J 2011; 57(1):21–29.
   PubMedGoogle Scholar
• Martinez FJ, Foster G, Curtis JL, Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173(12):1326–1334.
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23(6):932–946.
   PubMed Web of Science ®Google Scholar
• Arnardottir RH, Boman G, Larsson K, Hedenstrom H, Emtner M. Interval training compared with continuous training in patients with COPD. Respir Med 2007; 101(6):1196–1204.
   PubMed Web of Science ®Google Scholar
• Hedenstrom H, Malmberg P, Agarwal K. Reference values for lung function tests in females. Regression equations with smoking variables. Bull Eur Physiopathol Respir 1985; 21(6):551–557.
   PubMedGoogle Scholar
• Hedenstrom H, Malmberg P, Fridriksson HV. Reference values for lung function tests in men: regression equations with smoking variables. Ups J Med Sci 1986; 91(3):299–310.
   PubMed Web of Science ®Google Scholar
• Macintyre N, Crapo RO, Viegi G, Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26(4):720–735.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Standardisation of spirometry. Eur Respir J 2005; 26(2):319–338.
   PubMed Web of Science ®Google Scholar
• Wanger J, Clausen JL, Coates A, Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26(3):511–522.
   PubMed Web of Science ®Google Scholar
• Saetta M, Kim WD, Izquierdo JL, Ghezzo H, Cosio MG. Extent of centrilobular and panacinar emphysema in smokers’ lungs: pathological and mechanical implications. Eur Respir J 1994; 7(4):664–671.
   PubMed Web of Science ®Google Scholar
• Shaker SB, Stavngaard T, Hestad M, Bach KS, Tonnesen P, Dirksen A. The extent of emphysema in patients with COPD. Clin Respir J 2009; 3(1):15–21.
   PubMed Web of Science ®Google Scholar
• Klein JS, Gamsu G, Webb WR, Golden JA, Muller NL. High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. Radiology 1992; 182(3):817–821.
   PubMed Web of Science ®Google Scholar
• Tzani P, Aiello M, Colella M, Lung diffusion capacity can predict maximal exercise in apparently healthy heavy smokers. J Sport Sci Med 2008; 7(2):229–234.
   PubMed Web of Science ®Google Scholar
• Nagelmann A, Tonnov A, Laks T, Sepper R, Prikk K. Lung dysfunction of chronic smokers with no signs of COPD. COPD 2011; 8(3):189–195.
   PubMedGoogle Scholar
• Brown CD, Benditt JO, Sciurba FC, Exercise testing in severe emphysema: association with quality of life and lung function. COPD 2008; 5(2):117–124.
   PubMedGoogle Scholar
• Diaz O, Villafranca C, Ghezzo H, Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J. 2000; 16(2):269–275.
   PubMed Web of Science ®Google Scholar
• Guenette JA, Webb KA, O'Donnell DE. Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J 2012; 40(2):322–329.
   PubMed Web of Science ®Google Scholar
• Agusti A, Soriano JB. COPD as a systemic disease. COPD 2008; 5(2):133–138.
   PubMedGoogle Scholar
• Owens GR, Rogers RM, Pennock BE, Levin D. The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. N Engl J Med 1984; 310(19):1218–1221.
   PubMed Web of Science ®Google Scholar
• Vassaux C, Torre-Bouscoulet L, Zeineldine S, Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 2008; 32(5):1275–1282.
   PubMed Web of Science ®Google Scholar
• Carter R, Holiday DB, Nwasuruba C, Stocks J, Grothues C, Tiep B. 6-minute walk work for assessment of functional capacity in patients with COPD. Chest 2003; 123(5):1408–1415.
   PubMed Web of Science ®Google Scholar
• Buess C, Lehnigk B, Magnussen H. Comparison of two systems for measuring the carbon monoxide diffusing capacity of the lung. Am J Respir Crit Care Med 2010; 181(1_MeetingAbstracts):A6489.
   Google Scholar
• Sterner JB, Morris MJ, Sill JM, Hayes JA. Inspiratory flow-volume curve evaluation for detecting upper airway disease. Respir Care 2009; 54(4):461–466.
   PubMed Web of Science ®Google Scholar